Intuitive Surgical, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Intuitive Surgical, Inc. (ISRG) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $213.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-21
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $213.00M, a 7.25% increase year-over-year.
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $213.80M, a 15.01% increase year-over-year.
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $207.20M, a 15.43% increase year-over-year.
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $205.40M, a 17.17% increase year-over-year.
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $797.10M, a 16.67% increase from fiscal 2024.
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $683.20M, a 13.47% increase from fiscal 2023.
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $602.10M, a 14.77% increase from fiscal 2022.
- Intuitive Surgical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $524.60M, a 16.79% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $213.00M 10-Q · filed 2026-07-21 | $426.80M 10-Q · filed 2026-07-21 | $634.00M derived: sum of 3 quarters · filed 2026-07-21 | $839.40M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2026-03-31 | $213.80M 10-Q · filed 2026-04-22 | $421.00M derived: sum of 2 quarters · filed 2026-04-22 | $626.40M derived: sum of 3 quarters · filed 2026-04-22 | $825.00M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-12-31 | $207.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $412.60M derived: sum of 2 quarters · filed 2026-02-03 | $611.20M derived: sum of 3 quarters · filed 2026-07-21 | $797.10M 10-K · filed 2026-02-03 | |
| 2025-09-30 | $205.40M 10-Q · filed 2025-10-22 | $404.00M derived: sum of 2 quarters · filed 2026-07-21 | $589.90M 10-Q · filed 2025-10-22 | $769.40M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-06-30 | $198.60M 10-Q · filed 2026-07-21 | $384.50M 10-Q · filed 2026-07-21 | $564.00M derived: sum of 3 quarters · filed 2026-07-21 | $739.30M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-03-31 | $185.90M 10-Q · filed 2026-04-22 | $365.40M derived: sum of 2 quarters · filed 2026-04-22 | $540.70M derived: sum of 3 quarters · filed 2026-04-22 | $716.30M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-12-31 | $179.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $354.80M derived: sum of 2 quarters · filed 2026-02-03 | $530.40M derived: sum of 3 quarters · filed 2026-02-03 | $683.20M 10-K · filed 2026-02-03 | |
| 2024-09-30 | $175.30M 10-Q · filed 2025-10-22 | $350.90M derived: sum of 2 quarters · filed 2025-10-22 | $503.70M 10-Q · filed 2025-10-22 | $653.30M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-06-30 | $175.60M 10-Q · filed 2025-07-23 | $328.40M 10-Q · filed 2025-07-23 | $478.00M derived: sum of 3 quarters · filed 2026-02-03 | $636.30M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-03-31 | $152.80M 10-Q · filed 2025-04-23 | $302.40M derived: sum of 2 quarters · filed 2026-02-03 | $460.70M derived: sum of 3 quarters · filed 2026-02-03 | $608.90M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2023-12-31 | $149.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $307.90M derived: sum of 2 quarters · filed 2026-02-03 | $456.10M derived: sum of 3 quarters · filed 2026-02-03 | $602.10M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $158.30M 10-Q · filed 2024-10-18 | $306.50M derived: sum of 2 quarters · filed 2024-10-18 | $452.50M 10-Q · filed 2024-10-18 | $591.50M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-06-30 | $148.20M 10-Q · filed 2024-07-19 | $294.20M 10-Q · filed 2024-07-19 | $433.20M derived: sum of 3 quarters · filed 2025-01-31 | $571.30M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-03-31 | $146.00M 10-Q · filed 2024-04-19 | $285.00M derived: sum of 2 quarters · filed 2025-01-31 | $423.10M derived: sum of 3 quarters · filed 2025-01-31 | $549.80M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2022-12-31 | $139.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $277.10M derived: sum of 2 quarters · filed 2025-01-31 | $403.80M derived: sum of 3 quarters · filed 2025-01-31 | $524.60M 10-K · filed 2025-01-31 | |
| 2022-09-30 | $138.10M 10-Q · filed 2023-10-20 | $264.80M derived: sum of 2 quarters · filed 2023-10-20 | $385.60M 10-Q · filed 2023-10-20 | $503.40M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-06-30 | $126.70M 10-Q · filed 2023-07-24 | $247.50M 10-Q · filed 2023-07-24 | $365.30M derived: sum of 3 quarters · filed 2024-01-31 | $485.40M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-03-31 | $120.80M 10-Q · filed 2023-04-20 | $238.60M derived: sum of 2 quarters · filed 2024-01-31 | $358.70M derived: sum of 3 quarters · filed 2024-01-31 | $466.80M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2021-12-31 | $117.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $237.90M derived: sum of 2 quarters · filed 2024-01-31 | $346.00M derived: sum of 3 quarters · filed 2024-01-31 | $449.20M 10-K · filed 2024-01-31 | |
| 2021-09-30 | $120.10M 10-Q · filed 2022-10-21 | $228.20M derived: sum of 2 quarters · filed 2022-10-21 | $331.40M 10-Q · filed 2022-10-21 | $434.50M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-06-30 | $108.10M 10-Q · filed 2022-07-22 | $211.30M 10-Q · filed 2022-07-22 | $314.40M derived: sum of 3 quarters · filed 2023-02-10 | $420.20M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-03-31 | $103.20M 10-Q · filed 2022-04-22 | $206.30M derived: sum of 2 quarters · filed 2023-02-10 | $312.10M derived: sum of 3 quarters · filed 2023-02-10 | $408.00M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2020-12-31 | $103.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $208.90M derived: sum of 2 quarters · filed 2023-02-10 | $304.80M derived: sum of 3 quarters · filed 2023-02-10 | $395.40M 10-K · filed 2023-02-10 | |
| 2020-09-30 | $105.80M 10-Q · filed 2021-10-20 | $201.70M derived: sum of 2 quarters · filed 2021-10-20 | $292.30M 10-Q · filed 2021-10-20 | $381.50M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-06-30 | $95.90M 10-Q · filed 2021-07-21 | $186.50M 10-Q · filed 2021-07-21 | $275.70M derived: sum of 3 quarters · filed 2022-02-03 | $364.60M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-03-31 | $90.60M 10-Q · filed 2021-04-21 | $179.80M derived: sum of 2 quarters · filed 2022-02-03 | $268.70M derived: sum of 3 quarters · filed 2022-02-03 | $350.30M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2019-12-31 | $89.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $178.10M derived: sum of 2 quarters · filed 2022-02-03 | $259.70M derived: sum of 3 quarters · filed 2022-02-03 | $335.80M 10-K · filed 2022-02-03 | |
| 2019-09-30 | $88.90M 10-Q · filed 2020-10-19 | $170.50M derived: sum of 2 quarters · filed 2020-10-19 | $246.60M 10-Q · filed 2020-10-19 | $316.90M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-06-30 | $81.60M 10-Q · filed 2020-07-23 | $157.70M 10-Q · filed 2020-07-23 | $228.00M derived: sum of 3 quarters · filed 2021-02-10 | $298.10M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-03-31 | $76.10M 10-Q · filed 2020-04-17 | $146.40M derived: sum of 2 quarters · filed 2021-02-10 | $216.50M derived: sum of 3 quarters · filed 2021-02-10 | $279.80M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2018-12-31 | $70.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $140.40M derived: sum of 2 quarters · filed 2021-02-10 | $203.70M derived: sum of 3 quarters · filed 2021-02-10 | $261.20M 10-K · filed 2021-02-10 | |
| 2018-09-30 | $70.10M 10-Q · filed 2019-10-18 | $133.40M derived: sum of 2 quarters · filed 2019-10-18 | $190.90M 10-Q · filed 2019-10-18 | ||
| 2018-06-30 | $63.30M 10-Q · filed 2019-07-22 | $120.80M 10-Q · filed 2019-07-22 | |||
| 2018-03-31 | $57.50M 10-Q · filed 2019-04-19 | ||||
| 2017-12-31 | $209.10M 10-K · filed 2020-02-07 | ||||
| 2016-12-31 | $177.60M 10-K · filed 2019-02-04 | ||||
| 2015-12-31 | $167.90M 10-K · filed 2018-02-02 | ||||
| 2014-12-31 | $168.90M 10-K · filed 2017-02-06 | ||||
| 2013-12-31 | $168.90M 10-K · filed 2016-02-02 | ||||
| 2012-12-31 | $153.30M 10-K · filed 2015-02-06 | ||||
| 2011-12-31 | $136.40M 10-K · filed 2014-02-03 | ||||
| 2010-12-31 | $117.60M 10-K · filed 2013-02-04 | ||||
| 2009-12-31 | $97.00M 10-K · filed 2012-02-06 | $96.98M 10-K · filed 2010-01-29 | |||
| 2008-12-31 | $76.60M 10-K · filed 2011-02-01 | $76.65M 10-K · filed 2010-01-29 | |||
| 2007-12-31 | $36.28M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |